title: The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.
abstract: For a proper development of the placenta, maternal NK cells should not attack the fetal extravillous cytotrophoblast cells. This inhibition of maternal NK cells is partially mediated via the nonclassical MHC class I molecule HLA-G. Recently, we demonstrated that HLA-G forms disulfide-linked high molecular complexes on the surface of transfected cells. In the present study, we demonstrate that HLA-G must associate with beta(2)m for its interaction with CD85J/leukocyte Ig-like receptor-1 (LIR-1). Although HLA-G free H chain complexes are expressed on the surface, they are not recognized and possibly interfere with CD85J/LIR-1 and HLA-G interaction. The formation of these complexes on the cell surface might represent a novel mechanism developed specifically by the HLA-G protein aimed to control the efficiency of the CD85J/LIR-1-mediated inhibition. We also show that endogenous HLA-G complexes are expressed on the cell surface. These findings provide novel insights into the delicate interaction between extravillous cytotrophoblast cells and NK cells in the decidua.
authors.affiliation: The Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
authors.forename: Tsufit
authors.initials: T
authors.lastname: Gonen-Gross
authors.forename: Hagit
authors.initials: H
authors.lastname: Achdout
authors.forename: Tal I
authors.initials: TI
authors.lastname: Arnon
authors.forename: Roi
authors.initials: R
authors.lastname: Gazit
authors.forename: Noam
authors.initials: N
authors.lastname: Stern
authors.forename: Václav
authors.initials: V
authors.lastname: Horejsí
authors.forename: Debra
authors.initials: D
authors.lastname: Goldman-Wohl
authors.forename: Simcha
authors.initials: S
authors.lastname: Yagel
authors.forename: Ofer
authors.initials: O
authors.lastname: Mandelboim
mesh_terms: D015703:Antigens, CD / Q000502:physiology*; D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D006680:HLA Antigens / Q000378:metabolism*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D007694:Killer Cells, Natural / Q000502:physiology; D000075362:Leukocyte Immunoglobulin-like Receptor B1; D010206:Papain; D011971:Receptors, Immunologic / Q000502:physiology*; D001613:beta 2-Microglobulin / Q000378:metabolism*
chemical_list: D015703:Antigens, CD; D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; C105299:LILRB1 protein, human; D000075362:Leukocyte Immunoglobulin-like Receptor B1; D011971:Receptors, Immunologic; D001613:beta 2-Microglobulin; D010206:Papain